Journaling for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain

This study is looking at whether journaling can help people with Temporomandibular Disorder (TMD), which causes jaw pain, and other long-lasting pain conditions. You would be asked to participate in either a gratitude journaling group, where you write down three things you're grateful for, or a general wellness journaling group, where you reflect on daily activities. Both journaling activities are done at home three days a week for two weeks. The researchers want to see if these journaling activities are easy to do and if people find them helpful. They will also look at how satisfied participants are and if journaling helps reduce pain and its impact on daily life. To join, you need to be between 18 and 80 years old, have jaw pain for at least 3 months with an average pain score of 4 or higher, and also have another chronic pain condition like fibromyalgia or migraines.

Study design
This interventional study plans to enroll 60 participants. It compares two different journaling activities: gratitude journaling and general wellness journaling.
What's involved
You would journal from home three days a week for two weeks. The study will measure your retention from baseline to week 4 and your treatment satisfaction at week 4.
Compensation
Not stated in the trial record.
Follow-up
Your participation will be assessed for retention from the start of the study until week 4. Treatment satisfaction will be measured at week 4.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06977100

Journaling Intervention for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain

Recruiting
NAAges 18–80InterventionalTreatment
University of Florida
~60 participants
Updated 2026-06-29 on ClinicalTrials.gov
What's tested:GratitudeGeneral Wellness

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Participant Retention
Measured over Baseline to Week 4
+1 more outcome measured
Temporomandibular Disorders (TMD)
1 sites across 1 states
Florida1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

participants between the ages of 18 and 80
pain in the temporomandibular (TMD) region (jaw and/or temple area)
duration of pain is at least 3 months
average pain score ≥4 on a 0-10 numerical rating scale over the past week
have at least one additional chronic overlapping pain condition (COPC) including fibromyalgia, irritable bowel syndrome, migraine-type headache, tension-type headache, low back pain, interstitial cystitis/painful bladder syndrome or chronic prostatitis, myalgic encephalomyelitis/chronic fatigue syndrome, vulvodynia, and painful endometriosis.
able to read, understand, and write in English.

Exclusion

history of TMD surgery
neoplasm or injury/trauma to the TMD area
cancer-related pain
scheduled for any surgeries during the study time-frame
current participation in another clinical trial or psychological treatment for any pain-related condition that would interfere with study outcomes
pregnant or lactating
severe motor impairments (e.g., muscular dystrophy)
severe psychiatric conditions (e.g., uncontrolled mood disorders)
severe neurological or cognitive impairments (e.g., uncontrolled Parkinson's disease)
any other conditions that in the opinion of study investigators could make participation in the study unsafe
use of opioids within 48 hours prior to laboratory visit
  • Participant RetentionBaseline to Week 4

    Percentage of participants who initiate treatment/intervention and complete the post-intervention assessment at the 4-week time-point.

  • Treatment SatisfactionWeek 4

    Single-item Treatment Satisfaction Questionnaire: Response to self-reported item assessing overall satisfaction with the treatment. The item is rated on a 1 to 4 scale (1 = Quite Dissatisfied to 4 = Very Satisfied) with the mean value calculated. A higher score indicates greater satisfaction with the treatment.